eshwarsstg
SEBI CLARIFIES THAT MONITORING CORPORATE GOVERNANCE COMPLIANCE CANNOT BE DELEGATED
The Securities and Exchange Board of India (“SEBI”), through an informal guidance dated 6 February 2026 has clarified that the quarterly compliance report on corporate governance required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“LODR Regulations”) must necessarily be placed before the Board of Directors, and that oversight by a committee of … Read more
SEBI Adjudication Order in the Matter of Accretion Pharmaceuticals Limited: Forward-Looking Statements in IPO Communications Under Scrutiny
1. SEBI had conducted an examination to assess possible violations of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (“ICDR Regulations”) and the SEBI (Merchant Bankers) Regulations, 1992 (“MB Regulations”) in relation to Accretion Pharmaceuticals Limited (being the “Issuer Company” in its IPO) and Jawa Capital Services Private Limited (being the “Book Running … Read more
SEBI MANDATES DISCLOSURE OF REGISTRATION DETAILS BY REGULATED ENTITIES ON SOCIAL MEDIA PLATFORMS
SEBI vide its circular dated 26 February 2026 (Circular No.: HO/(79)2026-MIRSD-PODMMC) (“Circular”) has introduced disclosure requirements for SEBI-regulated entities and their agents while posting securities market related content on Social Media Platforms (“SMPs”). The Circular forms part of SEBI’s Ease of Doing Investment (EoDI) initiative and seeks to enhance transparency by enabling investors to clearly … Read more
SEBI ISSUES CIRCULAR TO DEPOSITORIES IN RELATION TO CREATION/ INVOCATION OF PLEDGE OF SECURITIES THROUGH DEPOSITORIES
SEBI vide its circular dated 5 February 2026 (HO/47/14/12(1)2026-MRD-POD2/I/4229/2026) (“Circular”) has come forth with certain inclusions to the framework for pledging of shares as prescribed under Paragraph 4.13 of the Master Circular for Depositories dated 3rd December 2024 (“Master Circular”) read with the SEBI (Depositories and Participants) Regulations, 2018 (“DP Regulations”). Alignment with the provisions … Read more
SEBI ORDER IN THE MATTER OF EIKO LIFESCIENCES LIMITED: DISCLOSURE OBLIGATIONS FOR PROMOTER ENCUMBRANCES REVISITED
SEBI had, through its adjudication order dated 5th January 2026 (“Order”), passed an order after examining a Draft Letter of Offer (DLoF) filed in connection with a proposed acquisition of shares of Eiko Lifesciences Limited (‘Company’) by Lenus Finvest Private Limited, a promoter entity of the Company. The examination was with respect to potential non-compliance … Read more
SEBI SIMPLIFIES ACCREDITATION REQUIREMENTS FOR INVESTORS UNDER AIF FRAMEWORK
SEBI has issued a circular dated 9 January 2026 (Circular No.:HO/19/34/11(9)2025-AFD-POD1/I/2286/2026) (“Circular”) introducing further simplifications to the framework governing grant of accreditation to investors under the SEBI (Alternative Investment Funds) Regulations, 2012 (“AIF Regulations”). The accredited investor framework was originally introduced pursuant to amendments made to the AIF Regulations as notified on 3 August 2021. … Read more